We initially investigated pan-cancer the expression of YY1 and PEBP1, and found higher YY1 mRNA levels in HNSC, lung cancer (both LUAD and LUSC), ESCA, BRCA, and BLCA, compared to their corresponding normal tissues. Here, PEBP1 is linked to bladder transitional cell carcinoma.